Joy Fridey

1.6k total citations
22 papers, 883 citations indexed

About

Joy Fridey is a scholar working on Immunology, Management of Technology and Innovation and Ecology, Evolution, Behavior and Systematics. According to data from OpenAlex, Joy Fridey has authored 22 papers receiving a total of 883 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Immunology, 9 papers in Management of Technology and Innovation and 6 papers in Ecology, Evolution, Behavior and Systematics. Recurrent topics in Joy Fridey's work include T-cell and Retrovirus Studies (10 papers), Blood donation and transfusion practices (9 papers) and Animal Disease Management and Epidemiology (6 papers). Joy Fridey is often cited by papers focused on T-cell and Retrovirus Studies (10 papers), Blood donation and transfusion practices (9 papers) and Animal Disease Management and Epidemiology (6 papers). Joy Fridey collaborates with scholars based in United States, Germany and Canada. Joy Fridey's co-authors include Edward L. Murphy, Catharie C. Nass, George B. Schreiber, Bruce Newman, George Garratty, Simone A. Glynn, James W. Smith, Debra Kessler, Joan Gibble and R. A. Sacher and has published in prestigious journals such as Blood, Neurology and The Journal of Infectious Diseases.

In The Last Decade

Joy Fridey

21 papers receiving 857 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joy Fridey United States 15 469 338 287 279 147 22 883
R.A. Thomson United States 14 265 0.6× 217 0.6× 181 0.6× 299 1.1× 176 1.2× 19 901
Edward L. Murphy United States 12 326 0.7× 280 0.8× 230 0.8× 105 0.4× 38 0.3× 23 669
Fernando Augusto Proietti Brazil 17 220 0.5× 142 0.4× 134 0.5× 22 0.1× 350 2.4× 34 756
J. Peter Figueroa Jamaica 9 174 0.4× 147 0.4× 128 0.4× 9 0.0× 36 0.2× 10 341
L Diakhaté Senegal 10 58 0.1× 34 0.1× 29 0.1× 46 0.2× 37 0.3× 51 398
Veronica C. Hoad Australia 13 23 0.0× 28 0.1× 19 0.1× 113 0.4× 100 0.7× 55 440
A. Massougbodji Benin 11 93 0.2× 45 0.1× 37 0.1× 16 0.1× 146 1.0× 39 380
Cesar de Almeida‐Neto Brazil 16 39 0.1× 12 0.0× 8 0.0× 250 0.9× 140 1.0× 73 717
Jean Emmanuel Zimbabwe 13 34 0.1× 16 0.0× 12 0.0× 57 0.2× 44 0.3× 30 550
Selma K. Dritz United States 4 89 0.2× 18 0.1× 13 0.0× 26 0.1× 28 0.2× 5 323

Countries citing papers authored by Joy Fridey

Since Specialization
Citations

This map shows the geographic impact of Joy Fridey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joy Fridey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joy Fridey more than expected).

Fields of papers citing papers by Joy Fridey

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joy Fridey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joy Fridey. The network helps show where Joy Fridey may publish in the future.

Co-authorship network of co-authors of Joy Fridey

This figure shows the co-authorship network connecting the top 25 collaborators of Joy Fridey. A scholar is included among the top collaborators of Joy Fridey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joy Fridey. Joy Fridey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rajbhandary, Srijana, Chester Andrzejewski, Joy Fridey, et al.. (2022). Incorporating the entity of under‐transfusion into hemovigilance monitoring: Documenting cases due to lack of inventory. Transfusion. 62(3). 540–545. 6 indexed citations
2.
Rajbhandary, Srijana, Nancy L. Van Buren, Mark Fung, et al.. (2021). The safety of COVID‐19 convalescent plasma donation: A multi‐institutional donor hemovigilance study. Transfusion. 61(9). 2668–2676. 5 indexed citations
3.
Fridey, Joy, Susan L. Stramer, Ashok Nambiar, et al.. (2020). Sepsis from an apheresis platelet contaminated with Acinetobacter calcoaceticus/baumannii complex bacteria and Staphylococcus saprophyticus after pathogen reduction. Transfusion. 60(9). 1960–1969. 18 indexed citations
4.
Horth, Roberta, Jefferson M. Jones, Janice Kim, et al.. (2018). Fatal Sepsis Associated with Bacterial Contamination of Platelets — Utah and California, August 2017. MMWR Morbidity and Mortality Weekly Report. 67(25). 718–722. 31 indexed citations
5.
Ruccione, Kathleen S., et al.. (2011). Association of projected transfusional iron burden with treatment intensity in childhood cancer survivors. Pediatric Blood & Cancer. 59(4). 697–702. 25 indexed citations
6.
Biswas, Hope H., Zhanna Kaidarova, George Garratty, et al.. (2010). Increased All-Cause and Cancer Mortality in HTLV-II Infection. JAIDS Journal of Acquired Immune Deficiency Syndromes. 54(3). 290–296. 36 indexed citations
7.
Biswas, Hope H., John W. Engstrom, Zhanna Kaidarova, et al.. (2009). Neurologic abnormalities in HTLV-I– and HTLV-II–infected individuals without overt myelopathy. Neurology. 73(10). 781–789. 47 indexed citations
8.
Kaidarova, Zhanna, Dale F. Hirschkorn, Ronald A. Sacher, et al.. (2008). Long-term increases in lymphocytes and platelets in human T-lymphotropic virus type II infection. Blood. 112(10). 3995–4002. 46 indexed citations
9.
Kaidarova, Zhanna, Dale F. Hirschkorn, Ronald A. Sacher, et al.. (2008). Long-Term Increases in Lymphocytes and Platelets in Human T-Lymphotropic Virus Type II Infection. Blood. 112(11). 4900–4900.
10.
11.
Sánchez, Ana M., George B. Schreiber, Catharie C. Nass, et al.. (2005). The impact of male‐to‐male sexual experience on risk profiles of blood donors. Transfusion. 45(3). 404–413. 49 indexed citations
12.
Murphy, Edward L., Baoguang Wang, Ronald A. Sacher, et al.. (2004). Respiratory and Urinary Tract Infections, Arthritis, and Asthma Associated with HTLV-I and HTLV-II Infection. Emerging infectious diseases. 10(1). 109–116. 83 indexed citations
13.
Glynn, Simone A., Alan Williams, Catharie C. Nass, et al.. (2003). Attitudes toward blood donation incentives in the United States: implications for donor recruitment. Transfusion. 43(1). 7–16. 126 indexed citations
14.
Damesyn, Mark, Simone A. Glynn, George B. Schreiber, et al.. (2003). Behavioral and infectious disease risks in young blood donors: implications for recruitment. Transfusion. 43(11). 1596–1603. 41 indexed citations
15.
Engstrom, John W., Joy Fridey, R. A. Sacher, et al.. (2003). Prevalence and clinical features of HTLV neurologic disease in the HTLV Outcomes Study. Neurology. 61(11). 1588–1594. 124 indexed citations
16.
Murphy, Edward L., Simone A. Glynn, Joy Fridey, et al.. (1998). Laboratory Test Differences Associated With HTLV-I and HTLV-II Infection. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology. 17(4). 332–338. 9 indexed citations
17.
Fridey, Joy. (1997). Practical aspects of out-of-hospital transfusion.. PubMed. 107(4 Suppl 1). S64–71. 13 indexed citations
18.
Murphy, Edward L., Joy Fridey, James W. Smith, et al.. (1997). HTLV-associated myelopathy in a cohort of HTLV-I and HTLV-II-infected blood donors. Neurology. 48(2). 315–320. 102 indexed citations
19.
Murphy, Edward L., Simone A. Glynn, Joy Fridey, et al.. (1997). Increased Prevalence of Infectious Diseases and Other Adverse Outcomes in Human T Lymphotropic Virus Types I‐ and II‐Infected Blood Donors. The Journal of Infectious Diseases. 176(6). 1468–1475. 66 indexed citations
20.
Fridey, Joy, et al.. (1994). Out-Of-Hospital Transfusion Therapy. Medical Entomology and Zoology. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026